Coavetherapeutics Is A Clinical Stagebiotechnology Company Based In Parisfrancefocused On Genetic Medicinethecompany Specializes In Developing Genetherapies For Rareneurodegenerativeneuromuscularand Ocular Diseasescoaveoperates Labs At Theinstitut Du Cerveau Et Dela Moellea Pinia Reicmand Has Recently Expanded Into Theu Smarket Thecompany Utilizes Its Proprietary Aligatera C Platform To Enhancegenetherapy Delivery To Extra Hepatic Tissuesimproving Precision And Safetythis Technology Allows For Targeted Delivery To Thecentral Nervous System And Eyesutilizing Chemically Engineered Aav Vectors To Increasetissuespecificity And Therapeutic Efficacycoaves Pipelineincludes Genetherapies For Rarediseaseswith Promising Preclinical Data On Its Engineered Aav Vectors For Cns Applications Coavetherapeutics Aims To Translateinnovativescienceinto Impactful Therapies For Patients With Raregenetic Disordersthecompany Collaborates With Research Institutions And Investorsfocusing On Partnerships With Global Biopharmaceutical Entities To Advanceits Mission
